Publisher
Springer International Publishing
Reference47 articles.
1. U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labels. USFDA, Silver Spring. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm. Accessed Jun 2020.
2. Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. Am J Manag Care. 2004;10(7 Pt 1):425–32.
3. Verhoef TI, Redekop WK, van Schie RM, Bayat S, Daly AK, Geitona M, et al. Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics. 2012;13(12):1405–17. https://doi.org/10.2217/pgs.12.124.
4. Payne K, Shabaruddin FH. Cost-effectiveness analysis in pharmacogenomics. Pharmacogenomics. 2010;11(5):643–6. https://doi.org/10.2217/pgs.10.45.
5. Phillips KA, Van Bebber SL. A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics. 2004;5(8):1139–49. https://doi.org/10.1517/14622416.5.8.1139.